EUPHROSYNE INVESTMENT LIMITEDActive
Key figures
Like most small UK companies, EUPHROSYNE INVESTMENT LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2025/26Balance sheet structure
Filed accounts2022/23–2025/26
| 2022/23 | 2023/24 | 2024/25 | 2025/26 | |
|---|---|---|---|---|
| Cash at bank and in hand | — | 10,009 | 10,043 | 7 |
| Total assets | 800,100 | 790,104 | 730,138 | 711,102 |
| Total liabilities | — | — | — | — |
| Net assets / total equity | 55 | -1,104 | -1,744 | -2,436 |
| Average number of employees | 0 | 0 | 0 | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Summary: EUPHROSYNE INVESTMENT LIMITED
Company
EUPHROSYNE INVESTMENT LIMITED is a private limited company registered with Companies House under company number 13831332. It was incorporated on 5 Jan 2022. Its status is active. The registered office is in Oxford (OX2). Its nature of business (SIC 2007) is activities of open-ended investment companies (64304), activities of head offices (70100).
Accounts
The latest accounts in the database are for 2025/26 (period ending 31 Jan 2026); the company files small company accounts (filleted). Net assets were −£2,436, down 39.7% on the previous year. Cash at bank and in hand was £7. The company had an average of 0 employees. Figures are available for 4 financial years (2022/23–2025/26).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 31 Oct 2026. The next confirmation statement is due by 5 Mar 2027.